What is a Non-Caseating Granuloma in Sarcoidosis?
At a Glance
A non-caseating granuloma is a tightly packed cluster of immune cells that forms when the immune system overreacts in sarcoidosis. "Non-caseating" means it lacks a core of dead tissue. They most commonly form in the lungs and may resolve on their own or require treatment if they threaten organs.
In this answer
3 sections
When you are diagnosed with sarcoidosis, you will often hear the term “non-caseating granuloma.” A granuloma is a tightly packed cluster of immune cells that forms when your body tries to wall off something it perceives as a threat. In sarcoidosis, these granulomas are described as non-caseating, which simply means they do not have a core of dead, “cheese-like” tissue in the center [1]. This lack of dead tissue helps doctors distinguish sarcoidosis from other diseases, like tuberculosis, which typically cause “caseating” (dead-center) granulomas [1][2].
While granulomas can form anywhere in the body, the lungs and nearby lymph nodes are by far the most common locations, affecting more than 90% of people with sarcoidosis.
How Do Granulomas Form?
Your immune system acts as a defense force to protect your body. In sarcoidosis, this defense force becomes hyperactive and starts overreacting, even when there is no obvious infection [3][4]. The formation of a granuloma involves two main types of immune cells working together:
- Macrophages: These are the “clean-up” cells of the immune system. In sarcoidosis, macrophages become highly activated and gather together, sometimes merging into large, multi-nucleated “giant cells” [5][6].
- T-cells: These act as the “managers” that direct the immune response. Certain types of T-cells (especially Th1 and Th17 cells) release chemical signals that recruit more macrophages and keep them permanently switched on [7][4].
This continuous signaling loop between T-cells and macrophages creates a snowball effect [3][8]. The cells clump tightly together to form the solid, microscopic structures known as non-caseating granulomas [1][6].
How Do Granulomas Affect Your Body?
Granulomas are tiny, often microscopic, but they can cause significant problems when large numbers of them gather in one place. Their accumulation can disrupt your health in a few main ways:
- Displacing Normal Tissue: As granulomas multiply, they take up space. In delicate organs like the lungs, heart, or eyes, these clusters of immune cells get in the way of normal functioning [9][10]. For example, if granulomas fill the spaces between the air sacs in your lungs, it becomes harder for oxygen to enter your bloodstream.
- Ongoing Inflammation: The immune cells inside the granulomas constantly release inflammatory chemicals [11][8]. This chronic inflammation can make you feel fatigued, achy, or generally unwell, even if the granulomas are only located in one organ.
- Risk of Scarring (Fibrosis): In many people, granulomas eventually disappear on their own or with treatment. However, if the inflammation persists for a long time, the body may try to heal the area by laying down scar tissue, a process called fibrosis [12][11]. Unlike granulomas, which can shrink or resolve, scar tissue is permanent and can affect the organ’s structure [12][10]. Fortunately, the goal of regular medical monitoring is to catch and treat severe inflammation long before it reaches this stage.
Monitoring and Treatment
Because many granulomas eventually shrink or disappear without intervention, and because treatments like corticosteroids can have significant side effects, doctors often recommend an active “watch and wait” approach. Treatment is usually only prescribed if the granulomas are causing severe symptoms or threatening organ function [13][11].
During this time, your doctor will track the size and impact of the granulomas using tools like chest X-rays, pulmonary function tests, and symptom tracking. If treatment becomes necessary, medications like corticosteroids work by interrupting the signals between T-cells and macrophages, slowing down the immune system so the granuloma clusters can shrink [13][11].
Common questions in this guide
What does "non-caseating" mean?
Where do granulomas usually form in sarcoidosis?
Do non-caseating granulomas cause permanent damage?
Do all sarcoidosis granulomas need to be treated with medication?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Are my granulomas currently affecting my organ function in a way that requires immediate treatment?
- 2.Is it safe to monitor my condition right now with a 'watch and wait' approach, or do we need to start treatment?
- 3.What specific tests (like X-rays or pulmonary function tests) will we use to track whether my granulomas are growing or shrinking?
- 4.If we need to start treatment, how will we balance the goal of shrinking the granulomas against the potential side effects of the medication?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (13)
- 1
Sarcoidosis, Mycobacterium paratuberculosis and Noncaseating Granulomas: Who Moved My Cheese.
Dow CT, Lin NW, Chan ED
Microorganisms 2023; (11(4)) doi:10.3390/microorganisms11040829.
PMID: 37110254 - 2
Neurosarcoidosis: A Unique Presentation of a Rare Disease.
Girgis K, Retcho D, Pesenti R, et al.
Cureus 2023; (15(11)):e48499 doi:10.7759/cureus.48499.
PMID: 38073923 - 3
Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis.
Bernardinello N, Petrarulo S, Balestro E, et al.
Diagnostics (Basel, Switzerland) 2021; (11(9)) doi:10.3390/diagnostics11091558.
PMID: 34573900 - 4
Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome.
Miedema JR, de Jong LJ, van Uden D, et al.
Journal of autoimmunity 2024; (149()):103120 doi:10.1016/j.jaut.2023.103120.
PMID: 37863732 - 5
Transcriptional and Immune Landscape of Cardiac Sarcoidosis.
Liu J, Ma P, Lai L, et al.
Circulation research 2022; (131(8)):654-669 doi:10.1161/CIRCRESAHA.121.320449.
PMID: 36111531 - 6
A Rare Skin Lesion Presentation With Sarcoidosis.
Hashem S, Harby R, Al-Sabah H, Allafi A
Cureus 2024; (16(8)):e67269 doi:10.7759/cureus.67269.
PMID: 39301395 - 7
T-bet Expression in Peripheral Th17.0 Cells Is Associated With Pulmonary Function Changes in Sarcoidosis.
Arger NK, Machiraju S, Allen IE, et al.
Frontiers in immunology 2020; (11()):1129 doi:10.3389/fimmu.2020.01129.
PMID: 32774332 - 8
The Renin-Angiotensin-Aldosterone System Regulates Sarcoidosis Granulomatous Inflammation.
Crouser ED, Julian MW, Locke LW, et al.
American journal of respiratory and critical care medicine 2024; (210(4)):497-507 doi:10.1164/rccm.202402-0265OC.
PMID: 38941161 - 9
Infliximab or biosimilars in sarcoidosis; to switch or not to switch?
Veltkamp M, Drent M, Baughman RP
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2016; (32(4)):280-3.
PMID: 26847093 - 10
Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis.
Gerke AK
Journal of clinical medicine 2024; (13(3)) doi:10.3390/jcm13030738.
PMID: 38337432 - 11
Dexamethasone alleviates pulmonary sarcoidosis by regulating the TGF-β/Smad3 signaling to promote Th17/Treg cell rebalance.
Zhang Y, Jiang X, Wang Q, et al.
Cellular immunology 2024; (395-396()):104781 doi:10.1016/j.cellimm.2023.104781.
PMID: 38159414 - 12
Matrix Metalloproteinase-12 Is Required for Granuloma Progression.
Mohan A, Neequaye N, Malur A, et al.
Frontiers in immunology 2020; (11()):553949 doi:10.3389/fimmu.2020.553949.
PMID: 33072094 - 13
Imbalanced distribution of regulatory T cells and Th17.1 cells in the peripheral blood and BALF of sarcoidosis patients: relationship to disease activity and the fibrotic radiographic phenotype.
Zhang H, Jiang D, Zhu L, et al.
Frontiers in immunology 2023; (14()):1185443 doi:10.3389/fimmu.2023.1185443.
PMID: 37520566
This page explains non-caseating granulomas for educational purposes only and does not replace professional medical advice. Always consult your healthcare provider about your sarcoidosis symptoms and treatment plan.
Get notified when new evidence is published on Sarcoidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.